[1] Jover R, Lourido D, Gonzalez C, et al. Role of PET/CT in the evaluation of cervical cancer. Gynecol Oncol, 2008, 110 Suppl 2: S55-59.
[2] 鲁霞. PET显像在妇科疾病中的应用.医学信息, 2011, 24(7): 319.
[3] Schwarz JK, Grigsby PW, Dehdashti F, et al. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries. J Nucl Med, 2009, 50 Suppl 1: S64-73.
[4] Patel CN, Nazir SA, Khan Z, et al. 18F-FDG PET /CT of cervical carcinoma. AJR Am J Roentgenol, 2011, 196(5): 1225-1233.
[5] 邓凯, 张成琪. PET-CT在妇科恶性肿瘤诊断中的应用.山东医药, 2006, 46(3): 75-76.
[6] Grisaru D, Almog B, Levine C, et al. The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignancies. Gynecol Oncol, 2004, 94(3): 680-684.
[7] 贾承晔, 于丽娟, 段钰. 18F-FDG PET/CT在妇科恶性肿瘤转移与复发中的应用.中国医学影像技术, 2009, 25(8): 1473-1476.
[8] 宋武战, 池君, 洪瑜, 等. 18F-FDG PET-CT对妇科肿瘤定性诊断的准确性.西南国防医药, 2011, 21(12): 1291-1293.
[9] Loft A, Berthelsen AK, Roed H, et al. The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol, 2007, 106(1): 29-34.
[10] Subhas N, Patel PV, Pannu HK, et al. Imaging of pelvic malignancies with in-line FDG PET-CT: case examples and common pitfalls of FDG PET. Radiographics, 2005, 25(4): 1031-1043.
[11] Huang B, Law MW, Khong PL. Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. Radiology, 2009, 251(1): 166-174.